Namita Thapar of Shark Tank India Responds to Trolls Over Namaz Health Benefits
Synopsis
Key Takeaways
New Delhi, April 20 (NationPress) Namita Thapar, a judge on Shark Tank India and the Executive Director of Emcure Pharmaceuticals, responded assertively to online trolls on Monday after experiencing backlash for her comments regarding the health advantages of namaz, which she shared on Instagram in March.
Thapar revealed that she and her mother faced a barrage of abusive remarks following her social media post, which prompted her to vocally address what she described as selective outrage.
She challenged the criticism, noting that her previous remarks concerning the positive effects of Surya Namaskar did not provoke similar responses.
In a video message, Thapar, portraying herself as a healthcare expert and a dedicated Hindu, asserted that religion should embody respect, particularly towards women, urging individuals to oppose any form of disrespect.
She advised the trolls to 'proceed at your own risk', emphasizing that actions carry consequences.
“I have always believed that ‘R for Religion’ translates to ‘R for Respect’. Is this how we define respect, especially for women? When women face disrespect, why is there such silence?” she questioned, advocating for self-advocacy.
Thapar also encouraged the trolls to “carry on”, yet warned them about the repercussions of their actions, referencing the principle of karma.
In a post on X, she mentioned that she recorded the video early in the morning before her workday because she believes 'silence is not a virtue' and that individuals should voice their concerns against actions that violate fundamental human rights.
While accustomed to online trolling over recent years, she emphasized that her message aimed to inspire others to speak out against injustices 'for the sake of humanity and patriotism'.
On the financial front, shares of Emcure Pharmaceuticals dipped by as much as 3.12 percent on Monday, reaching an intra-day low of Rs 1,618. However, the stock rebounded to close at Rs 1,628, a decrease of Rs 44.10 or 2.64 percent. The stock has recorded a 52-week high of Rs 1,688 and a low of Rs 950 on the exchange.